NCT02191098View on ClinicalTrials.gov

Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 9, 2019

Study Completion Date

September 9, 2019

Conditions
HIVStable ART
Interventions
DRUG

ALT-803

Interleukin 15 (IL-15) is a common γ-chain cytokine that is related to interleukin-2 (IL-2) and is a critical factor for the development, proliferation, and activation of effector natural killer (NK) and CD8+ memory T cells

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02191098 - Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People | Biotech Hunter | Biotech Hunter